8. Assessment of Subject Safety and Data Safety Monitoring Plan: All patients will be followed by one of the study investigators to ensure there are no complications associated with sugammadex administration (flushing, tachycardia, hypotension, etc). There are no expected complications of RVM monitoring. There are no expected complications associated with TOF monitoring, and in fact, such monitoring has been shown to improve patient safety by decreasing postoperative CREs and other complications.